# OnCo record paper-javelin-merkel-200-lancet-oncol-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-javelin-merkel-200-lancet-oncol-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-javelin-merkel-200-lancet-oncol-2016" ;
  schema:name "Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial"@en ;
  schema:description "Published report from the JAVELIN Merkel 200 trial registered as NCT02155647, in The Lancet Oncology (2016), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-javelin-merkel-200-lancet-oncol-2016/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(16)30364-3>, <https://pubmed.ncbi.nlm.nih.gov/27592805/>, <https://europepmc.org/article/MED/27592805>, <https://clinicaltrials.gov/study/NCT02155647> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(16)30364-3> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Kaufman HL, Russell J, Hamid O, et al." ;
  onco:trials <https://onco.cc/trials/javelin-merkel-200/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .